Assuntos
Sobrevivência de Enxerto/imunologia , Tolerância Imunológica , Transplante de Pele/imunologia , Linfócitos T/transplante , Transplante Homólogo/imunologia , Animais , Soro Antilinfocitário/farmacologia , Citotoxicidade Imunológica , Feminino , Transplante de Tecido Fetal/imunologia , Linfoma/imunologia , Linfoma/patologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Transplante de Neoplasias/imunologia , Ratos , Ratos Endogâmicos Lew , Linfócitos T/imunologia , Timo/imunologia , Timo/transplante , Fatores de Tempo , Transplante Heterólogo/imunologiaAssuntos
Dextranos , Sobrevivência de Enxerto , Intestino Delgado/transplante , Soluções para Preservação de Órgãos , Preservação de Órgãos/métodos , Adenosina , Alopurinol , Animais , Cães , Glutationa , Insulina , Intestino Delgado/patologia , Intestino Delgado/fisiologia , Soluções Isotônicas , Rafinose , Lactato de Ringer , Soluções , Transplante Autólogo , Transplante HeterotópicoRESUMO
Little is known about the microvascular effects of blood replacement solutions. This study was undertaken to develop an animal model suitable for studies of the microcirculatory effects of such solutions and to investigate microvascular responses to isovolemic transfusion with stroma-free hemoglobin (SFH), whole donor blood, or a new potential blood substitute solution containing oxypolyhemoglobin (OPH) as an oxygen carrier. Hamster livers were exposed and the microcirculation studied using intravital epifluorescent video microscopy. 33% blood volume replacement with SFH elevated systemic blood pressure by 25 Torr. Accompanying this increase in pressure was a 36% decrease in sinusoidal blood flow velocity and a 10% decrease in terminal hepatic venular diameters. Terminal portal venular diameters did not change. Decrease in liver sinusoidal perfusion was not due to neutrophil mediated injury, as myeloperoxidase activity in jejunum, liver, kidney, and lung remained unchanged. The reduction in perfusion was likely due to systemic vasoconstriction produced by SFH. In contrast, transfusion with whole blood did not change any of the measured parameters showing the excellent stability of the model. OPH transfused animals exhibited only a small 10 Torr transient increase in MAP 15 min post-transfusion. By 30 min MAP returned to the pre-infusion value. No significant changes were observed in either venular diameters or sinusoidal velocities in this group of animals. These results demonstrate suitability of this model for studies of the microcirculatory and hemodynamic effects of blood replacement solutions. Furthermore, OPH solution produced only minor transient disturbances in microvascular and systemic parameters.
Assuntos
Circulação Sanguínea/efeitos dos fármacos , Substitutos Sanguíneos/farmacologia , Hemodinâmica/efeitos dos fármacos , Hemoglobinas/farmacologia , Fígado/efeitos dos fármacos , Animais , Velocidade do Fluxo Sanguíneo/efeitos dos fármacos , Pressão Sanguínea/efeitos dos fármacos , Cateterismo , Cricetinae , Frequência Cardíaca/efeitos dos fármacos , Hematócrito , Masculino , Mesocricetus , Microcirculação/efeitos dos fármacos , Modelos Biológicos , Oxiemoglobinas/farmacologia , Vasodilatação/efeitos dos fármacosRESUMO
The delayed contralateral nephrectomy procedure (three-step) produced inconsistent results, indicating that the preserved autotransplanted kidney tends to remain unfunctional and to regenerate incompletely unless the demand for work is placed upon it. Omission of HES in UW (UW-plain) did not affect preservation success, but resulted in increased graft edema. Substitution of HES in UW with plasma (SGF-V) or albumin (MAlb) gave significantly worse results than UW-like solutions with or without synthetic colloids. Replacement of HES in UW with UMdex-70 or UMdex-500 gave nonsignificantly worse results than UW-like solutions with or without synthetic colloids. The use of UMdex-40 as the main colloid in UW cheapened the solution, equalled the preservation success of UW and UW-plain but surpassed UW-plain in edema prevention, and exceeded UW concerning recovery of graft microcirculation.
Assuntos
Proteínas Sanguíneas , Dextranos , Derivados de Hidroxietil Amido , Transplante de Rim/fisiologia , Rim , Soluções para Preservação de Órgãos , Preservação de Órgãos/métodos , Albumina Sérica , Soluções , Adenosina , Alopurinol , Animais , Coloides , Cães , Feminino , Glutationa , Humanos , Insulina , Transplante de Rim/patologia , Masculino , RafinoseRESUMO
An intravenous solution of 99% pure globulin (hyperimmune IgG, HIVIG) was obtained from pooled plasma of selected human immunodeficiency virus (HIV-1)-seropositive asymptomatic donors with greater than 400 CD4+/microliters cells per microliter and a high titer of antibody to HIV-1 p24 protein. HIVIG had high titers of antibody to p24, glycoprotein 41 (gp41), and gp120, group-specific neutralizing activity, and binding to the gp120 hypervariable loop region. It inhibited syncytia formation. At low concentration, it enhanced viral production of HIV-1 in infected peripheral blood monocytes but was inhibitory at higher concentration. HIVIG directed group-specific antibody-dependent cellular cytotoxicity against HIV-infected targets. For a period of 6 to 28 months, plasma donors kept stable antibody titers and had a 1.0% decrease in CD4+ cells per month. One gram per kilogram HIVIG injected in two juvenile chimpanzees was well tolerated and did not transmit HIV, as measured by negative cell culture, IgM immune response to HIV proteins, and polymerase chain reaction. The mean half-life of HIV-1 p24 antibody was 15 days. These preliminary data suggest that HIVIG is a safe product suitable for clinical trial in HIV-1-infected individuals.
Assuntos
Anticorpos Anti-HIV/isolamento & purificação , Soropositividade para HIV/imunologia , HIV/imunologia , Imunoglobulinas Intravenosas/isolamento & purificação , Animais , Citotoxicidade Celular Dependente de Anticorpos , Efeito Citopatogênico Viral , Anticorpos Anti-HIV/administração & dosagem , Antígenos HIV/análise , Humanos , Imunização Passiva , Isotipos de Imunoglobulinas/imunologia , Imunoglobulinas Intravenosas/administração & dosagem , Injeções Intravenosas , Testes de Neutralização , Pan troglodytes , Plasmaferese , Linfócitos T/imunologiaAssuntos
Anticorpos Monoclonais/uso terapêutico , Antígenos de Diferenciação de Linfócitos T/imunologia , Sobrevivência de Enxerto , Imunização Passiva , Receptores de Antígenos de Linfócitos T/imunologia , Transplante de Pele/imunologia , Linfócitos T/imunologia , Animais , Complexo CD3 , Feminino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Timectomia , Timo/imunologia , Transplante Heterólogo , Transplante HomólogoRESUMO
Antibody-containing plasma from patients recovered from Argentine hemorrhagic fever (AHF) is of proven value in treatment of the acute disease, but the possibility of transmitting blood-borne organisms such as HIV and hepatitis virus detracts from this approach. Purified human immune plasma fractions IgG1,2,4, IgG1,2,3,4 and F(ab')2 neutralized Junin virus in vitro. IgG1,2,3,4 and IgG1,2,4 lysed (in the presence of complement) cells infected with Junin virus, and protected infected guinea pigs from AHF. However, large quantities of the immune F(ab')2 fraction from the same plasma pool failed to protect guinea pigs from death, to increase the mean time to death, and to diminish virus load in target organs of infected guinea pigs. This suggests that elimination of infected cells rather than virus neutralization may play a critical role in protection against Junin virus.
Assuntos
Arenavirus do Novo Mundo/imunologia , Citotoxicidade Imunológica/efeitos dos fármacos , Febre Hemorrágica Americana/prevenção & controle , Imunização Passiva , Fragmentos Fab das Imunoglobulinas/administração & dosagem , Imunoglobulina G/administração & dosagem , Animais , Cobaias , Meia-Vida , Febre Hemorrágica Americana/mortalidade , Fragmentos Fab das Imunoglobulinas/isolamento & purificação , Fragmentos Fab das Imunoglobulinas/farmacocinética , Imunoglobulina G/isolamento & purificação , Imunoglobulina G/farmacocinética , Masculino , Células VeroAssuntos
Rejeição de Enxerto/efeitos dos fármacos , Imunossupressores/farmacologia , Transplante de Pele/imunologia , Transplante Heterólogo/imunologia , Animais , Antibacterianos/farmacologia , Cricetinae , Ciclofosfamida/farmacologia , Ciclosporinas/farmacologia , Relação Dose-Resposta a Droga , Quimioterapia Combinada , Transplante de Coração/imunologia , Transplante das Ilhotas Pancreáticas , Mesocricetus , Camundongos , Camundongos Endogâmicos , Prednisona/farmacologia , Ratos , Ratos Endogâmicos Lew , Suínos , Tacrolimo , Transplante Heterotópico/imunologiaAssuntos
Anticorpos Monoclonais/imunologia , Anticorpos/imunologia , Terapia de Imunossupressão , Linfócitos T/imunologia , Animais , Antígenos de Diferenciação de Linfócitos T/imunologia , Complexo CD3 , Feminino , Leucemia L1210/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Transplante de Neoplasias , Ratos , Receptores de Antígenos de Linfócitos T/imunologia , Transplante HomólogoAssuntos
Antígenos de Diferenciação/imunologia , Soro Antilinfocitário/imunologia , Epitopos/análise , Linfócitos/imunologia , Animais , Células Cultivadas , Imunofluorescência , Cabras/imunologia , Cavalos/imunologia , Humanos , Terapia de Imunossupressão , Coelhos/imunologia , Especificidade da EspécieAssuntos
Rejeição de Enxerto , Transplante de Coração , Reação Hospedeiro-Enxerto , Transplante Heterólogo , Animais , Anticorpos Monoclonais/uso terapêutico , Ciclosporinas/uso terapêutico , Terapia de Imunossupressão , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Ratos , Ratos Endogâmicos LewRESUMO
Heterologous horse antithymocyte globulins (ATG) were investigated in vitro as potential immunotherapeutic reagents in the prevention of bone marrow graft rejection by allogeneic recipients. Different lots and concentrations of ATG were evaluated for their ability to inactivate natural killer (NK) cells, IL-2 cultured 'augmented' NK cells, and/or cytotoxic T cells (CTL) using the 51Cr-release assay for measurement of cytotoxic activity. In vitro incubation of peripheral blood mononuclear cells (PBMC) with a prototype non-myelotoxic ATG (ATGP12) at 0.1 mg/ml (a concentration which can be achieved with an i.v. infusion of approximately 30 mg ATG/kg daily) variously inhibited NK activity (0-100%); whereas treatment with the same concentration of ATGP12 and autologous human complement completely inhibited NK, as well as 'augmented' NK function from all normal individuals tested. Incubation of T cytotoxic effector cells with ATGP12 alone also significantly abrogated primed T cell cytotoxicity. These studies demonstrate that lots of ATG can be easily prescreened and titered in vitro in order to identify immunosuppressive reagents capable of inhibiting the MHC restricted and non-restricted cytotoxic cells, which can survive chemotherapy and radiation, and may play a critical role in resistance to engraftment of T cell-depleted marrow.
Assuntos
Soro Antilinfocitário , Células da Medula Óssea , Proteínas do Sistema Complemento/farmacologia , Rejeição de Enxerto , Depleção Linfocítica , Transplante de Medula Óssea , Células Cultivadas , Testes Imunológicos de Citotoxicidade , Humanos , Interleucina-2/farmacologia , Células Matadoras Naturais/efeitos dos fármacos , Células Matadoras Naturais/imunologia , Linfócitos T Citotóxicos/imunologiaRESUMO
Both monoclonal antibody (MAb) and polyclonal antibody (PAb) directed against the shared core/lipid A region of lipopolysaccharide (LPS) (endotoxin) provide protection during experimental gram-negative bacterial sepsis. Although these preparations have not been compared, clinical trials administering either preparation to septic patients have been instituted. The core/lipid A region of LPS represents an antigenic domain common to many, if not all, gram-negative microbes, and thus represents an ideal target site for antibody binding. We sought to determine (1) the protective capacity of similarly reactive IgG anti-core LPS/lipid A MAbs and PAbs, (2) whether the timing of administration was important, and (3) whether either would act additively with antimicrobial agents. Antibody was administered intravenously to outbred mice, and Escherichia coli 0111:B4 was then administered intravenously or intraperitoneally with hemoglobin. Monoclonal antibodies and PAbs were equally protective, and protection was maximized by pretreatment, although the effect extended to four hours after bacterial challenge. Both MAbs and PAbs acted in concert with gentamicin hydrochloride to further reduce lethality. We concluded that MAbs and PAbs were equally protective and that clinical utility may eventually be dictated by ease and cost of antibody production.
Assuntos
Anticorpos Monoclonais/imunologia , Anticorpos/imunologia , Infecções Bacterianas/imunologia , Endotoxinas/imunologia , Infecções Bacterianas/prevenção & controle , Lipopolissacarídeos/imunologiaRESUMO
The observations presented here confirm previous reports that polyclonal ALG prepared at the University of Minnesota or ATGAM of The Upjohn Co., administered as described, rarely induced sensitization of patients to the horse gamma globulin. In addition, the phenomena of transient antibody production prior to the onset of unresponsiveness and the induction of unresponsiveness in individuals with preexisting antibodies were observed.
Assuntos
Soro Antilinfocitário/imunologia , Imunologia de Transplantes , Animais , Formação de Anticorpos , Soro Antilinfocitário/uso terapêutico , Transplante de Medula Óssea , Sobrevivência de Enxerto , Cavalos , Humanos , Tolerância Imunológica , Transplante de RimRESUMO
Although the ability of the gut-associated lymphoid tissue (GALT) to respond to orally ingested foreign antigens has been studied extensively, its function in preventing or limiting escape of resident gut bacteria has not been assessed. The following studies were performed to examine what role cell-mediated immunity (CMI) plays in this process. The ability of suppression of CMI to induce escape of gut bacteria (translocation) to the mesenteric lymph node (MLN) in immunocompetent mice whose gut flora was unaltered was examined. Administration of cyclosporine or anti-L3T4 antibody failed to induce translocation of indigenous gut bacteria after 7 or 14 days of treatment. Antithymocyte globulin (ATG) also failed to induce translocation after 7 days of treatment, despite depletion of all Thy 1, Lyt 1, L3T4, and Lyt 2 positive cells from the spleen, MLN, and intestine as demonstrated by immunofluorescent microscopy. Finally, cultures of the MLN, spleen, liver, and peritoneum of T cell-deficient BALB/c nude mice and their heterozygous T cell-replete littermates were also sterile, demonstrating that congenital suppression of T CMI also does not lead to translocation of indigenous gut bacteria. The role of CMI in limiting systemic spread of bacteria that were already translocating to the MLN was also examined. Translocation of Escherichia coli C25 to the MLN was induced by gastrointestinal (GI) monoassociation, which leads to translocation of E. coli C25 to the MLN in 80-100% of mice. Treatment with ATG during monoassociation failed to induce spread of E. coli C25 to the spleen, liver, or peritoneum, despite the same degree of T cell depletion achieved with ATG in the previous experiment. Monoassociation of conventional T cell-deficient BALB/c nude and heterozygous mice and germ-free T cell-deficient BALB/c nude and heterozygous mice also did not lead to spread of E. coli C25 beyond the MLN. However, in ATG-treated, conventional nude, and germ-free nude mice, the average number of translocating E. coli C25 per MLN was consistently higher. In separate experiments the ability of stimulation of T cell function to inhibit translocation of E. coli C25 was examined. Recombinant interleukin-2, 25,000 units, was administered intraperitoneally every 8 hours during exposure to E. coli C25. This reduced the incidence of translocation of E. coli C25 from 85% to 51% (p = 0.02). Suppression of CMI, either systemically or within the GALT, has a minimal influence on the mechanisms by which the normal gut flora are translocated to the MLN.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
Infecção Hospitalar/imunologia , Infecções por Escherichia coli/imunologia , Intestinos/microbiologia , Linfonodos/microbiologia , Mesentério/microbiologia , Linfócitos T/imunologia , Animais , Soro Antilinfocitário/farmacologia , Ciclosporinas/farmacologia , Feminino , Imunofluorescência , Tolerância Imunológica , Imunidade Celular , Interleucina-2/farmacologia , Intestinos/imunologia , Linfonodos/imunologia , Camundongos , Camundongos EndogâmicosRESUMO
Hemoglobin solutions were assessed in terms of their ability to promote lipid peroxidation, which was quantitated by measuring the formation of thiobarbituric acid reactive substances (TBARS) under specified conditions in murine brain homogenates. Solutions designed for use in acute treatment of hypovolemic shock and trauma should incorporate ingredients specifically aimed at decreasing oxygen and lipid radical mediated injury occurring secondary to ischemia and reperfusion. A number of strategies aimed at decreasing the oxidant effect of hemoglobin solutions and other blood and plasma substitutes have been evaluated. These include use of the naturally occurring anti-oxidants in human plasma, specifically transferrin and ceruloplasmin. Similarly, certain iron chelators, such as deferoxamine (Desferal, Ciba-Geigy), effectively prevent molecular and cellular damage caused by iron catalyzed formation of oxygen derived radicals.